| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2002-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c41865433432e0b8e1b60dea81865b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00aa386fce0a245a302b228d94f7afa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cdb2bc20eb5e82bbe9b432eb76a9581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1801b04989d280bbdb9503785c3dbfe5 |
| publicationDate |
2003-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003199586-A1 |
| titleOfInvention |
Unique levothyroxine aqueous materials |
| abstract |
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005232991-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7195779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007122476-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7052717-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004013725-A1 |
| priorityDate |
2001-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |